TET1 and ovarian carcinoma: TET1 suppressed pancreatic tumor proliferation, migration, and invasion in vivo and in vitro via inhibiting the Wnt/β-catenin signaling pathway, which is consistent with results found for colon and ovarian cancer [27, 28].